Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 2
1984 1
1986 2
1987 1
1988 4
1989 4
1990 3
1991 3
1992 4
1993 5
1994 6
1995 2
1996 4
1997 1
1998 6
1999 6
2000 2
2001 6
2002 4
2003 6
2004 11
2005 6
2006 11
2007 5
2008 7
2009 8
2010 16
2011 13
2012 14
2013 12
2014 19
2015 16
2016 10
2017 20
2018 15
2019 21
2020 12
2021 13
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
Corboy JR, Fox RJ, Kister I, Cutter GR, Morgan CJ, Seale R, Engebretson E, Gustafson T, Miller AE; DISCOMS investigators. Corboy JR, et al. Lancet Neurol. 2023 Jul;22(7):568-577. doi: 10.1016/S1474-4422(23)00154-0. Lancet Neurol. 2023. PMID: 37353277 Clinical Trial.
Author response.
Hartung DM, Bourdette DN, Whitham RH. Hartung DM, et al. Among authors: bourdette dn. Neurology. 2015 Nov 10;85(19):1727. Neurology. 2015. PMID: 26866070 No abstract available.
Author response.
Hartung DM, Bourdette DN, Ahmed S, Whitham RH. Hartung DM, et al. Among authors: bourdette dn. Neurology. 2015 Nov 10;85(19):1728. Neurology. 2015. PMID: 26866072 No abstract available.
The Challenges of Treating Late-Onset Multiple Sclerosis.
Bourdette D, Wooliscroft L. Bourdette D, et al. Neurology. 2024 Mar 26;102(6):e209146. doi: 10.1212/WNL.0000000000209146. Epub 2024 Feb 23. Neurology. 2024. PMID: 38394474 No abstract available.
Elephant in the room.
Hartung DM, Johnston K, Cohen DM, Nguyen T, Deodhar AA, Bourdette DN. Hartung DM, et al. Among authors: bourdette dn. Ann Rheum Dis. 2019 Feb;78(2):e11. doi: 10.1136/annrheumdis-2018-213008. Epub 2018 Jan 23. Ann Rheum Dis. 2019. PMID: 29363509 No abstract available.
Approaches to Remyelination Therapies in Multiple Sclerosis.
Wooliscroft L, Silbermann E, Cameron M, Bourdette D. Wooliscroft L, et al. Among authors: bourdette d. Curr Treat Options Neurol. 2019 Jun 28;21(7):34. doi: 10.1007/s11940-019-0574-1. Curr Treat Options Neurol. 2019. PMID: 31250211 Review.
285 results